Xencor | Ativo Circulante

Current Assets Alterar Data
AbbVie USD 38.87B 5.65B 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Amgen USD 28.03B 2.3B 2024-03
Arrowhead Research USD 541.65M 303.75M 2024-03
AstraZeneca USD 25.59B 540M 2024-03
Biogen USD 6.76B 103.1M 2024-03
Bristol-Myers Squibb USD 28.67B 1.04B 2024-03
Cytokinetics USD 638.7M 10.65M 2024-03
GlaxoSmithKline GBP 17.21B 1.44B 2024-03
J&J USD 57B 3.3B 2024-03
MacroGenics USD 202.58M 48.76M 2024-03
Merck USD 31.44B 509M 2024-03
Novartis USD 26.45B 4.03B 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
Xencor USD 562.25M 60.91M 2024-03



Xencor Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.